Fulcrum Therapeutics Inc (FULC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -70,819 | -82,677 | -32,588 | -22,964 | N/A |
| Depreciation Amortization | 2,379 | 2,053 | 1,345 | 715 | N/A |
| Accounts receivable | -2,531 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,773 | 803 | -20 | 208 | N/A |
| Other Working Capital | 7,503 | 11,326 | 6,522 | 804 | N/A |
| Other Operating Activity | 8,040 | 29,012 | 2,179 | 1,163 | 0 |
| Operating Cash Flow | $-53,655 | $-39,483 | $-22,562 | $-20,074 | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -55,796 | N/A | N/A | N/A | N/A |
| PPE Investments | -1,342 | -853 | -8,981 | -1,908 | N/A |
| Other Investing Activity | 0 | -91 | 0 | 0 | 0 |
| Investing Cash Flow | $-57,138 | $-944 | $-8,981 | $-1,908 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -50 | -45 | -70 | N/A | N/A |
| Common Stock Issued | 71,375 | 64,422 | 12 | 41 | N/A |
| Other Financing Activity | -193 | -34 | 105,083 | 17,621 | 0 |
| Financing Cash Flow | $71,132 | $64,343 | $105,025 | $17,662 | $N/A |
| Beginning Cash Position | 97,805 | 73,889 | 407 | 4,727 | N/A |
| End Cash Position | 58,144 | 97,805 | 73,889 | 407 | N/A |
| Net Cash Flow | $-39,661 | $23,916 | $73,482 | $-4,320 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -53,655 | -39,483 | -22,562 | -20,074 | N/A |
| Capital Expenditure | -1,342 | -853 | -8,981 | -1,908 | N/A |
| Free Cash Flow | -54,997 | -40,336 | -31,543 | -21,982 | 0 |